查看購物車
  • Simplified Chinese
  • English
2021-2031 年歐洲醫療第二意見市場報告（範圍、細分、動態和競爭分析）
市場調查報告書
商品編碼
1843415

2021-2031 年歐洲醫療第二意見市場報告（範圍、細分、動態和競爭分析）

Europe Medical Second Opinion Market Report 2021-2031 by Scope, Segmentation, Dynamics, and Competitive Analysis
出版日期: | 出版商: The Insight Partners | 英文 116 Pages | 訂單完成後即時交付

價格

預計歐洲醫療第二意見市場將大幅成長，到 2031 年將達到約 47.1417 億美元，高於 2023 年的 16.5244 億美元，預測期內的年複合成長率(CAGR) 為 14.0%。

執行摘要和市場分析

歐洲醫療第二診療意見市場的成長受到多種因素的推動，包括慢性病發病率的上升以及醫療詐欺案件的增加。此外，良好的監管環境、本土企業的存在以及提供第二診療意見服務的診所數量的不斷增加，也為該市場帶來了許多益處。

市場區隔

市場可以根據醫療條件和服務提供者進行細分。

1. 依疾病類型分類：市場分為幾類，包括癌症、骨科疾病、心臟疾病、神經系統疾病、腎臟疾病、血液系統疾病、慢性阻塞性肺病 (COPD)、器官移植等。值得注意的是，癌症領域在 2023 年佔據了最大的市場。

2. 按服務提供者分類：市場也按服務提供者細分，包括醫院、健康保險公司和線上服務。 2023年，醫院佔據了該細分市場的最大佔有率。

市場展望

第二醫療意見對於向患者提供有關其治療方案的全面資訊至關重要。它們有助於澄清針對單一病症的多種治療建議可能引起的困惑。此外，獲得第二醫療意見可以驗證診斷，從而提高治療的準確性。重視改善治療效果是市場成長的重要驅動力。鑑於各種治療方法都可能產生副作用，獲得合格醫療保健專業人員的第二醫療意見至關重要，尤其是在重症病例中。根據世界衛生組織 (WHO) 的數據，不安全的醫療行為每年導致全球超過 300 萬人死亡。 2022 年，全球報告的癌症相關死亡人數約為 970 萬，凸顯了對準確診斷和有效治療方案的迫切需求。癌症和其他慢性疾病的日益普及是推動第二醫療意見需求的關鍵因素。

國家洞察

歐洲醫療第二意見市場涵蓋多個國家，特別是德國、英國、法國、義大利、西班牙等。德國是2023年領先的市場。

在德國，由於慢性病（尤其是癌症）發生率的上升，預計市場將大幅擴張。癌症是導致發病和死亡的主要原因。世界衛生組織報告稱，2020年德國新增癌症病例628,519例，癌症相關死亡病例252,065例。這一令人擔憂的趨勢導致對精準診斷和治療方案的需求日益成長，促使癌症患者更頻繁地尋求第二診療意見。

德國政府已經認知到第二診療意見在醫療保健領域的重要性。 《德國病患權利憲章》保障病患尋求第二診療意見的權利，並要求醫療機構配合此類要求。德國知名的醫療機構，例如IMC Intermed-Consult，為尋求第二診療意見的國際患者提供全面的服務。此外，德國健康中心 (Germany Health) 也為包括癌症和骨科手術在內的各種疾病提供獨立醫學專家的評估。

本地市場參與者也為德國醫療第二意見市場的成長做出了貢獻。例如，腓特烈港診所推出了一項遠距諮詢服務，讓國際患者能夠以可負擔的價格獲得有價值的資訊和替代治療方案。

公司簡介

歐洲醫療第二意見市場的主要參與者包括 Second Opinion International、Elite Medical Services、The Cigna Group、Helsana、WorldCare、Vidal Health Insurance TPA Pvt Ltd、2nd.MD、Axa SA、Teladoc Health Inc、Included Health, Inc. 和 Royal Doctors 等。這些公司正在採用各種策略，包括擴張、產品創新和併購，以增強其產品服務並提升其市場佔有率。

目錄

第1章：簡介

第2章：執行摘要

  • 關鍵見解
  • 市場吸引力

第3章：研究方法

  • 二次研究
  • 初步研究
    • 假設表述：
    • 宏觀經濟因素分析：
    • 顯影基數：
    • 數據三角測量：
    • 國家級資料：

第4章：歐洲醫療第二意見市場－關鍵市場動態

  • 市場促進因素
    • 越來越重視更好的治療效果
    • 醫療成本最佳化的偏好日益增強
  • 市場限制
    • 新興國家對第二醫療意見缺乏認知且不願採納
  • 市場機會
    • 遠距醫療技術合作日益增多
  • 未來趨勢
    • 醫療諮詢服務數位化
  • 促進因素和限制因素的影響：

第5章：醫療第二意見市場－歐洲分析

  • 2021-2031年歐洲醫療第二意見市場收入
  • 歐洲醫療第二意見市場預測分析

第6章：歐洲醫療第二意見市場分析－依條件

  • 癌症
  • 骨科疾病
  • 心臟疾病
  • 神經系統疾病
  • 腎臟疾病
  • 血液系統疾病
  • 慢性阻塞性肺病
  • 器官移植
  • 其他

第7章：歐洲醫療第二意見市場分析－依服務提供者

  • 醫院
  • 健康保險公司
  • 線上服務

第8章：歐洲醫療第二意見市場－國家分析

  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區

第9章：產業格局

  • 概述
  • 醫療第二意見市場的成長策略
  • 有機成長策略
    • 概述
  • 無機成長策略
    • 概述

第10章：公司簡介

  • Second Opinion International
  • Elite Medical Services
  • The Cigna Group
  • Helsana
  • WorldCare
  • Vidal Health Insurance TPA Pvt Ltd
  • 2nd.MD
  • Axa SA
  • Teladoc Health Inc
  • Included Health, Inc.
  • Royal Doctors

第 11 章：附錄

Product Code: TIPRE00025236

The European medical second opinion market is projected to grow significantly, reaching approximately USD 4,714.17 million by 2031, up from USD 1,652.44 million in 2023, with a compound annual growth rate (CAGR) of 14.0% during the forecast period.

Executive Summary and Market Analysis

The growth of the medical second opinion market in Europe is driven by several factors, including the rising incidence of chronic diseases and an increase in healthcare fraud cases. The market benefits from a favorable regulatory environment, the presence of local players, and a growing number of clinics that offer second-opinion services.

Market Segmentation

The market can be segmented based on medical conditions and service providers.

1. By Condition: The market is divided into several categories, including cancer, orthopedic disorders, cardiac disorders, neurological disorders, nephrological disorders, hematological disorders, chronic obstructive pulmonary disease (COPD), organ transplants, and others. Notably, the cancer segment accounted for the largest market share in 2023.

2. By Service Provider: The market is also segmented by service providers, which include hospitals, health insurance companies, and online services. In 2023, hospitals held the largest share of this segment.

Market Outlook

Medical second opinions are crucial for providing patients with comprehensive information regarding their treatment options. They help clarify the confusion that may arise from multiple treatment recommendations for a single condition. Additionally, obtaining a second opinion can validate diagnoses, thereby enhancing treatment accuracy. The emphasis on improving treatment outcomes is a significant driver of market growth. Given the potential adverse effects of various treatments, obtaining a second opinion from a qualified healthcare professional is essential, especially in critical cases. According to the World Health Organization (WHO), unsafe medical practices contribute to over 3 million deaths annually worldwide. In 2022, approximately 9.7 million cancer-related deaths were reported globally, highlighting the urgent need for accurate diagnoses and effective treatment options. The increasing prevalence of cancer and other chronic diseases is a key factor propelling the demand for medical second opinions.

Country Insights

The European medical second opinion market includes several countries, notably Germany, the UK, France, Italy, Spain, and others. Germany was the leading market in 2023.

In Germany, the market is expected to expand significantly due to the rising rates of chronic diseases, particularly cancer, which is a leading cause of morbidity and mortality. The WHO reported 628,519 new cancer cases and 252,065 cancer-related deaths in Germany in 2020. This alarming trend has led to a heightened demand for accurate diagnostics and treatment options, prompting cancer patients to seek second opinions more frequently.

The German government has recognized the importance of second opinions in healthcare. The "Charter of Patients' Rights in Germany" ensures that patients have the right to seek a second medical opinion, mandating that healthcare providers cooperate with such requests. Notable healthcare providers in Germany, such as IMC Intermed-Consult, offer comprehensive services for international patients seeking second opinions. Additionally, Germany Health provides evaluations from independent medical experts for various conditions, including cancer and orthopedic surgeries.

Local market players are also contributing to the growth of the medical second opinion market in Germany. For instance, the Clinic of Friedrichshafen has introduced a tele-counseling service that allows international patients to access valuable information and alternative treatment options affordably.

Company Profiles

Key players in the European medical second opinion market include Second Opinion International, Elite Medical Services, The Cigna Group, Helsana, WorldCare, Vidal Health Insurance TPA Pvt Ltd, 2nd.MD, Axa SA, Teladoc Health Inc, Included Health, Inc., and Royal Doctors, among others. These companies are employing various strategies, including expansion, product innovation, and mergers and acquisitions, to enhance their offerings and increase their market presence.

Table Of Contents

1. Introduction

  • 1.1 Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights
  • 2.2 Market Attractiveness

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macroeconomic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country-level data:

4. Europe Medical Second Opinion Market - Key Market Dynamics

  • 4.1 Market Drivers
    • 4.1.1 Growing Emphasis on Better Treatment Outcomes
    • 4.1.2 Increasing Preference for Healthcare Cost Optimization
  • 4.2 Market Restraints
    • 4.2.1 Lack of Awareness and Reluctance Toward Adoption of Medical Second Opinion in Emerging Nations
  • 4.3 Market Opportunities
    • 4.3.1 Rising Collaborations in Telemedicine Technologies
  • 4.4 Future Trends
    • 4.4.1 Digitalization of Medical Consulting Services
  • 4.5 Impact of Drivers and Restraints:

5. Medical Second Opinion Market - Europe Analysis

  • 5.1 Europe Medical Second Opinion Market Revenue (US$ Million), 2021-2031
  • 5.2 Europe Medical Second Opinion Market Forecast Analysis

6. Europe Medical Second Opinion Market Analysis - by Condition

  • 6.1 Cancer
    • 6.1.1 Overview
    • 6.1.2 Cancer: Europe Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 6.2 Orthopedic Disorders
    • 6.2.1 Overview
    • 6.2.2 Orthopedic Disorders: Europe Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 6.3 Cardiac Disorders
    • 6.3.1 Overview
    • 6.3.2 Cardiac Disorders: Europe Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 6.4 Neurological Disorders
    • 6.4.1 Overview
    • 6.4.2 Neurological Disorders: Europe Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 6.5 Nephrological Disorders
    • 6.5.1 Overview
    • 6.5.2 Nephrological Disorders: Europe Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 6.6 Hematological Blood Disorders
    • 6.6.1 Overview
    • 6.6.2 Hematological Blood Disorders: Europe Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 6.7 COPD
    • 6.7.1 Overview
    • 6.7.2 COPD: Europe Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 6.8 Organ Transplant
    • 6.8.1 Overview
    • 6.8.2 Organ Transplant: Europe Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 6.9 Others
    • 6.9.1 Overview
    • 6.9.2 Others: Europe Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)

7. Europe Medical Second Opinion Market Analysis - by Service Provider

  • 7.1 Hospitals
    • 7.1.1 Overview
    • 7.1.2 Hospitals: Europe Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.2 Health Insurance Companies
    • 7.2.1 Overview
    • 7.2.2 Health Insurance Companies: Europe Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.3 Online Services
    • 7.3.1 Overview
    • 7.3.2 Online Services: Europe Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)

8. Europe Medical Second Opinion Market - Country Analysis

  • 8.1 Europe
    • 8.1.1 Europe Medical Second Opinion Market Overview
    • 8.1.2 Europe Medical Second Opinion Market - Revenue and Forecast Analysis - by Country
      • 8.1.2.1 Europe Medical Second Opinion Market - Revenue and Forecast Analysis - by Country
      • 8.1.2.2 Germany: Europe Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 8.1.2.2.1 Germany: Europe Medical Second Opinion Market Share - by Condition
        • 8.1.2.2.2 Germany: Europe Medical Second Opinion Market Share - by Service Provider
      • 8.1.2.3 United Kingdom: Europe Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 8.1.2.3.1 United Kingdom: Europe Medical Second Opinion Market Share - by Condition
        • 8.1.2.3.2 United Kingdom: Europe Medical Second Opinion Market Share - by Service Provider
      • 8.1.2.4 France: Europe Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 8.1.2.4.1 France: Europe Medical Second Opinion Market Share - by Condition
        • 8.1.2.4.2 France: Europe Medical Second Opinion Market Share - by Service Provider
      • 8.1.2.5 Italy: Europe Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 8.1.2.5.1 Italy: Europe Medical Second Opinion Market Share - by Condition
        • 8.1.2.5.2 Italy: Europe Medical Second Opinion Market Share - by Service Provider
      • 8.1.2.6 Spain: Europe Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 8.1.2.6.1 Spain: Europe Medical Second Opinion Market Share - by Condition
        • 8.1.2.6.2 Spain: Europe Medical Second Opinion Market Share - by Service Provider
      • 8.1.2.7 Rest of Europe: Europe Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 8.1.2.7.1 Rest of Europe: Europe Medical Second Opinion Market Share - by Condition
        • 8.1.2.7.2 Rest of Europe: Europe Medical Second Opinion Market Share - by Service Provider

9. Industry Landscape

  • 9.1 Overview
  • 9.2 Growth Strategies in Medical Second Opinion Market
  • 9.3 Organic Growth Strategies
    • 9.3.1 Overview
  • 9.4 Inorganic Growth Strategies
    • 9.4.1 Overview

10. Company Profiles

  • 10.1 Second Opinion International
    • 10.1.1 Key Facts
    • 10.1.2 Business Description
    • 10.1.3 Products and Services
    • 10.1.4 Financial Overview
    • 10.1.5 SWOT Analysis
    • 10.1.6 Key Developments
  • 10.2 Elite Medical Services
    • 10.2.1 Key Facts
    • 10.2.2 Business Description
    • 10.2.3 Products and Services
    • 10.2.4 Financial Overview
    • 10.2.5 SWOT Analysis
    • 10.2.6 Key Developments
  • 10.3 The Cigna Group
    • 10.3.1 Key Facts
    • 10.3.2 Business Description
    • 10.3.3 Products and Services
    • 10.3.4 Financial Overview
    • 10.3.5 SWOT Analysis
    • 10.3.6 Key Developments
  • 10.4 Helsana
    • 10.4.1 Key Facts
    • 10.4.2 Business Description
    • 10.4.3 Products and Services
    • 10.4.4 Financial Overview
    • 10.4.5 SWOT Analysis
    • 10.4.6 Key Developments
  • 10.5 WorldCare
    • 10.5.1 Key Facts
    • 10.5.2 Business Description
    • 10.5.3 Products and Services
    • 10.5.4 Financial Overview
    • 10.5.5 SWOT Analysis
    • 10.5.6 Key Developments
  • 10.6 Vidal Health Insurance TPA Pvt Ltd
    • 10.6.1 Key Facts
    • 10.6.2 Business Description
    • 10.6.3 Products and Services
    • 10.6.4 Financial Overview
    • 10.6.5 SWOT Analysis
    • 10.6.6 Key Developments
  • 10.7 2nd.MD
    • 10.7.1 Key Facts
    • 10.7.2 Business Description
    • 10.7.3 Products and Services
    • 10.7.4 Financial Overview
    • 10.7.5 SWOT Analysis
    • 10.7.6 Key Developments
  • 10.8 Axa SA
    • 10.8.1 Key Facts
    • 10.8.2 Business Description
    • 10.8.3 Products and Services
    • 10.8.4 Financial Overview
    • 10.8.5 SWOT Analysis
    • 10.8.6 Key Developments
  • 10.9 Teladoc Health Inc
    • 10.9.1 Key Facts
    • 10.9.2 Business Description
    • 10.9.3 Products and Services
    • 10.9.4 Financial Overview
    • 10.9.5 SWOT Analysis
    • 10.9.6 Key Developments
  • 10.10 Included Health, Inc.
    • 10.10.1 Key Facts
    • 10.10.2 Business Description
    • 10.10.3 Products and Services
    • 10.10.4 Financial Overview
    • 10.10.5 SWOT Analysis
    • 10.10.6 Key Developments
  • 10.11 Royal Doctors
    • 10.11.1 Key Facts
    • 10.11.2 Business Description
    • 10.11.3 Products and Services
    • 10.11.4 Financial Overview
    • 10.11.5 SWOT Analysis
    • 10.11.6 Key Developments

11. Appendix

  • 11.1 About Us
  • 11.2 List of Abbreviations

List Of Tables

  • Table 1. Europe Medical Second Opinion Market Segmentation
  • Table 2. Europe Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Table 3. Europe Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Condition
  • Table 4. Europe Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Service Provider
  • Table 5. Europe Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Country
  • Table 6. Germany: Europe Medical Second Opinion Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Condition
  • Table 7. Germany: Europe Medical Second Opinion Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Service Provider
  • Table 8. United Kingdom: Europe Medical Second Opinion Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Condition
  • Table 9. United Kingdom: Europe Medical Second Opinion Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Service Provider
  • Table 10. France: Europe Medical Second Opinion Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Condition
  • Table 11. France: Europe Medical Second Opinion Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Service Provider
  • Table 12. Italy: Europe Medical Second Opinion Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Condition
  • Table 13. Italy: Europe Medical Second Opinion Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Service Provider
  • Table 14. Spain: Europe Medical Second Opinion Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Condition
  • Table 15. Spain: Europe Medical Second Opinion Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Service Provider
  • Table 16. Rest of Europe: Europe Medical Second Opinion Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Condition
  • Table 17. Rest of Europe: Europe Medical Second Opinion Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Service Provider
  • Table 18. Recent Organic Growth Strategies in Medical Second Opinion Market
  • Table 19. Recent Inorganic Growth Strategies in the Medical Second Opinion Market
  • Table 20. List of Abbreviations

List Of Figures

  • Figure 1. Europe Medical Second Opinion Market Segmentation - Country
  • Figure 2. Europe Medical Second Opinion Market - Key Market Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Europe Medical Second Opinion Market Revenue (US$ Million), 2021-2031
  • Figure 5. Europe Medical Second Opinion Market Share (%) - by Condition (2023 and 2031)
  • Figure 6. Cancer: Europe Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 7. Orthopedic Disorders: Europe Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 8. Cardiac Disorders: Europe Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 9. Neurological Disorders: Europe Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 10. Nephrological Disorders: Europe Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 11. Hematological Blood Disorders: Europe Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 12. COPD: Europe Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 13. Organ Transplant: Europe Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 14. Others: Europe Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 15. Europe Medical Second Opinion Market Share (%) - by Service Provider (2023 and 2031)
  • Figure 16. Hospitals: Europe Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 17. Health Insurance Companies: Europe Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 18. Online Services: Europe Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 19. Europe Medical Second Opinion Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 20. Germany: Europe Medical Second Opinion Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 21. United Kingdom: Europe Medical Second Opinion Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 22. France: Europe Medical Second Opinion Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 23. Italy: Europe Medical Second Opinion Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 24. Spain: Europe Medical Second Opinion Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 25. Rest of Europe: Europe Medical Second Opinion Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 26. Growth Strategies in Medical Second Opinion Market